Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1995 | 1 |
1996 | 2 |
2014 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
J Virol. 2021 Mar 10;95(7):e02253-20. doi: 10.1128/JVI.02253-20. Epub 2021 Jan 13.
J Virol. 2021.
PMID: 33441339
Free PMC article.
The deltaE1/deltaE3 Ads are more popular because they can carry a larger transgene and because of the deleted E1 (E1A and E1B), are perceived safer for clinical use. Ad with a deletion in E1B55K (deltaE1B55K) has been in phase III clinical trials for use in cancer therapy …
The deltaE1/deltaE3 Ads are more popular because they can carry a larger transgene and because of the deleted E1 (E1A and E1B), are perceive …
Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus.
Sadeck LS, Leone CR, Procianoy RS, Guinsburg R, Marba ST, Martinez FE, Rugolo LM, Moreira ME, Fiori RM, Ferrari LL, Menezes JA, Venzon PS, Abdallah VQ, Duarte JL, Nunes MV, Anchieta LM, Alves Filho N.
Sadeck LS, et al.
J Pediatr (Rio J). 2014 Nov-Dec;90(6):616-23. doi: 10.1016/j.jped.2014.04.010. Epub 2014 Jul 19.
J Pediatr (Rio J). 2014.
PMID: 25046256
Free article.
OBJECTIVE: To analyze the effects of treatment approach on the outcomes of newborns (birth weight [BW] < 1,000 g) with patent ductus arteriosus (PDA), from the Brazilian Neonatal Research Network (BNRN) on: death, bronchopulmonary dysplasia (BPD), severe intraventricular hemor
…OBJECTIVE: To analyze the effects of treatment approach on the outcomes of newborns (birth weight [BW] < 1,000 g) with patent ductus arte
…
Item in Clipboard
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer.
Fisherman JS, Cowan KH, Noone M, Denicoff A, Berg S, Poplack D, Balis F, Venzon D, McCabe M, Goldspiel B, Chow C, Ognibene FP, O'Shaughnessy J.
Fisherman JS, et al.
J Clin Oncol. 1996 Mar;14(3):774-82. doi: 10.1200/JCO.1996.14.3.774.
J Clin Oncol. 1996.
PMID: 8622023
Clinical Trial.
Item in Clipboard
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.
Bitton RJ, Figg WD, Venzon DJ, Dalakas MC, Bowden C, Headlee D, Reed E, Myers CE, Cooper MR.
Bitton RJ, et al.
J Clin Oncol. 1995 Sep;13(9):2223-9. doi: 10.1200/JCO.1995.13.9.2223.
J Clin Oncol. 1995.
PMID: 7666080
Clinical Trial.
The rate of drug infusion was continuously adjusted to maintain a preassigned plasma suramin concentration (175, 215, or 275 micrograms/mL) for a fixed duration (2 to 8 weeks). RESULTS: Eight patients developed grade III/IV neurologic motor impairment (predominantly motor …
The rate of drug infusion was continuously adjusted to maintain a preassigned plasma suramin concentration (175, 215, or 275 micrograms/mL) …
Item in Clipboard
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group.
Lewis LL, Venzon D, Church J, Farley M, Wheeler S, Keller A, Rubin M, Yuen G, Mueller B, Sloas M, Wood L, Balis F, Shearer GM, Brouwers P, Goldsmith J, Pizzo PA.
Lewis LL, et al.
J Infect Dis. 1996 Jul;174(1):16-25. doi: 10.1093/infdis/174.1.16.
J Infect Dis. 1996.
PMID: 8655986
Clinical Trial.
Item in Clipboard
Cite
Cite